Allergan's Valeant Suit Could Be Landmark Securities Case
A lawsuit filed last week by Allergan Inc. against hostile takeover bidders Valeant Pharmaceuticals International Inc. and billionaire activist investor Bill Ackman could become a landmark case for insider trading securities...To view the full article, register now.
Already a subscriber? Click here to view full article